EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper

Ludger Klimek iD, Joaquim Mullol iD, Thomas Hummel iD, Stefano Del Giacco iD, Christos Georgalas iD, Carmen Rondon iD, Michele Schiappoli iD, Philippe Gevaert iD, Banu Bozkurt iD, Adam Chaker iD, Sietze Reitsma iD, Laura van Gerven iD and 29 more

Allergy · 2026-08 · 81 (8) · 2633-2655

DOI: 10.1111/all.70219 ↗

At a glance

Übersichtsarbeit in Allergy, published online on 2026-02-02. Written by Ludger Klimek and 40 co-authors. Institution: Center for Rhinology and Allergology, Wiesbaden, Germany. Major MEDLINE topics: Olfaction Disorders, Respiratory Tract Infections. Cited 1 times so far (Crossref); 305 references. The full text is freely available in PubMed Central. Funded by: European Academy of Allergy and Clinical Immunology.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The sense of smell, with its extensive evolutionary history, is highly prone to disorders that can have a profound impact on daily life. Anosmia affects approximately 5% of the population, with an additional 15% exhibiting reduced olfactory function. The prevalence of olfactory dysfunction (OD) varies by population and age group, and standardized testing reveals a broad range of impacts. OD includes various causes, most commonly aging, inflammation of the olfactory epithelium, upper respiratory tract infections (URTI), traumatic brain injury, and neurological conditions. The recent COVID‐19 pandemic has highlighted the association between viral infections and olfactory dysfunction, with severe hyposmia/anosmia being an early marker of infection. Despite its importance, the assessment of olfactory function remains inconsistent across clinical practices. Psychophysical smell tests, while vital for diagnosis and patient management, are underutilized, especially outside of specialized centers. Standardized testing methods are crucial for objective diagnosis, but significant challenges, including test variability, lack of comparability, and healthcare reimbursement issues, persist. The European Academy of Allergy and Immunology (EAACI) advocates for improvements in the quality and standardization of chemosensory assessments. Future efforts must prioritize education, incentives for better testing, and the integration of digital tools to expand access to olfactory testing and diagnosis in remote or quarantine situations. However, office‐based testing remains irreplaceable, even with advancements in telemedicine.

Subjects

MeSH terms (MEDLINE)

Olfaction DisordersRespiratory Tract InfectionsHumansCOVID-19SARS-CoV-2SmellAnosmiaPandemics

Author keywords

COVID‐19chemosensory functiongustationolfactiontasteupper airway disease

Authors and institutions

  • Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Department of Otorhinolaryngology, Hospital Clinic Barcelona, FRCB-IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain.
  • Smell and Taste Clinic, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Dresden, Dresden, Germany.
  • Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Medical School, University of Nicosia, Nicosia, Cyprus.
  • Allergy Unit, Hospital Regional Universitario de Malaga, Malaga, Spain.

ORCID profiles: Ludger Klimek, Joaquim Mullol, Thomas Hummel, Stefano Del Giacco, Christos Georgalas, Carmen Rondon, Michele Schiappoli, Philippe Gevaert, Banu Bozkurt, Adam Chaker, Sietze Reitsma, Laura van Gerven, Juan Maza-Solano, Sven Becker, Friederike Bärhold, Mandy Cuevas, Moritz Gröger, Patrick Huber, Stefania Arasi, Cemal Cingi, María Jesús Rojas-Lechuga, Adriana Izquierdo-Domínguez, Ioana Agache, Milena Sokolowska, Ian Adcock, Gulfem Celik, Maria Escribese, Jolanta Walusiak-Skorupa, Christian Betz, Oscar Palomares, André Moreira, Patrizia Bonadonna, Mohamed Shamji, María José Torres Jaen, Cezmi A Akdis, Jan Hagemann, Valerie Hox, Sanna Toppila-Salmi

Funding

  • European Academy of Allergy and Clinical Immunology

Cite

APA

Klimek, L., Mullol, J., Hummel, T., Del Giacco, S., Georgalas, C., Rondon, C., Schiappoli, M., Gevaert, P., Bozkurt, B., Chaker, A., Reitsma, S., van Gerven, L., Maza-Solano, J., Lundberg, M., Becker, S., Bärhold, F., Karavelia, A., Cuevas, M., Gröger, M., …, & Toppila-Salmi, S. (2026). The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper. Allergy, 81(8), 2633-2655. https://doi.org/10.1111/all.70219

Vancouver

Klimek L, Mullol J, Hummel T, Del Giacco S, Georgalas C, Rondon C, et al. The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper. Allergy. 2026;81(8):2633-2655. doi:10.1111/all.70219

BibTeX
@article{Klimek2026,
  author = {Klimek, Ludger and Mullol, Joaquim and Hummel, Thomas and Del Giacco, Stefano and Georgalas, Christos and Rondon, Carmen and Schiappoli, Michele and Gevaert, Philippe and Bozkurt, Banu and Chaker, Adam and Reitsma, Sietze and van Gerven, Laura and Maza-Solano, Juan and Lundberg, Marie and Becker, Sven and Bärhold, Friederike and Karavelia, Aspasia and Cuevas, Mandy and Gröger, Moritz and Huber, Patrick and Arasi, Stefania and Cingi, Cemal and Rojas-Lechuga, María Jesús and Izquierdo-Domínguez, Adriana and Agache, Ioana and Gawlik, Radek and Sokolowska, Milena and Adcock, Ian and Celik, Gulfem and Escribese, Maria and Walusiak-Skorupa, Jolanta and Betz, Christian and Palomares, Oscar and Moreira, André and Bonadonna, Patrizia and Shamji, Mohamed and Torres Jaen, María José and Akdis, Cezmi A and Hagemann, Jan and Hox, Valerie and Toppila-Salmi, Sanna},
  title = {The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {8},
  pages = {2633--2655},
  doi = {10.1111/all.70219}
}
Start for free →